Matt discusses one of his favorite long-term investment opportunities of a lifetime - Chinese Biotech. Brad Loncar of Loncar Investments joins Matt to talk about the booming biotech sector in China. Brad is the creator of the index that the China BioPharma ETF (CHNA) tracks. Brad shares his thoughts on a few stocks in the ETF and why he is so bullish on the sector. Matt also delves into the genetic testing sector and how it is the keystone to the future of health care.